The new filtration system utilizes the company's NanoStrike technology.
WellAir, a health technology company that focuses on indoor air disinfection solutions, has launched its new Defend NV 400 air filtration system. The Defend NV 400 is an FDA-cleared Class II medical device that is reportedly 99.9% effective against airborne pathogens, such as SARS-CoV-2, MRSA, and bacteria. It is also said to purify the air of particulate matter, volatile organic compounds, gases, and odors.
The new unit features WellAir’s NanoStrike™ technology—a method of air disinfection that bursts airborne pathogen cells, rapidly inactivating them to ensure they are no longer a threat.
The Defend NV 400 also utilities a 4-stage pathogen inactivation and filtration process with medical-grade filers from Camfil® to capture debris and large and fine particles.
The filtration system is said to produce no emissions or harmful by-products while it is portable throughout the office.